NOVAREX Co.Ltd (194700) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NOVAREX Co.Ltd (194700) has a cash flow conversion efficiency ratio of 0.041x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.73 Billion ≈ $7.27 Million USD) by net assets (₩260.64 Billion ≈ $176.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of NOVAREX Co.Ltd for the company's overall valuation and market capitalisation.
NOVAREX Co.Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how NOVAREX Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
NOVAREX Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NOVAREX Co.Ltd ranked by their cash flow conversion efficiency. Explore NOVAREX Co.Ltd (194700) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lalin Property Public Company Limited
BK:LALIN
|
-0.017x |
|
enGene Holdings Inc. Common Stock
NASDAQ:ENGN
|
-0.082x |
|
Monte Carlo Fashions Limited
NSE:MONTECARLO
|
-0.221x |
|
Neumora Therapeutics, Inc.
NASDAQ:NMRA
|
-0.353x |
|
Zapata Computing Holdings Inc. Common Stock
NASDAQ:ZPTA
|
0.032x |
|
vTv Therapeutics Inc
NASDAQ:VTVT
|
-0.029x |
|
Bank Negara Indonesia Tbk
JK:BBNI
|
0.385x |
|
Global Lithium Resources Ltd
AU:GL1
|
-0.020x |
Annual Cash Flow Conversion Efficiency for NOVAREX Co.Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of NOVAREX Co.Ltd from 2015 to 2025. View NOVAREX Co.Ltd (194700) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩254.64 Billion ≈ $172.57 Million |
₩16.65 Billion ≈ $11.28 Million |
0.065x | +8.25% |
| 2024-12-31 | ₩220.26 Billion ≈ $149.27 Million |
₩13.31 Billion ≈ $9.02 Million |
0.060x | -52.15% |
| 2023-12-31 | ₩200.42 Billion ≈ $135.82 Million |
₩25.30 Billion ≈ $17.15 Million |
0.126x | +13.88% |
| 2022-12-31 | ₩181.37 Billion ≈ $122.91 Million |
₩20.11 Billion ≈ $13.63 Million |
0.111x | -35.83% |
| 2021-12-31 | ₩139.67 Billion ≈ $94.65 Million |
₩24.13 Billion ≈ $16.35 Million |
0.173x | +22.84% |
| 2020-12-31 | ₩115.61 Billion ≈ $78.35 Million |
₩16.26 Billion ≈ $11.02 Million |
0.141x | +1093.29% |
| 2019-12-31 | ₩91.79 Billion ≈ $62.21 Million |
₩-1.30 Billion ≈ $-880.82K |
-0.014x | -115.01% |
| 2018-12-31 | ₩78.93 Billion ≈ $53.49 Million |
₩7.44 Billion ≈ $5.04 Million |
0.094x | -53.95% |
| 2017-12-31 | ₩51.88 Billion ≈ $35.16 Million |
₩10.62 Billion ≈ $7.20 Million |
0.205x | +23.86% |
| 2016-12-31 | ₩44.62 Billion ≈ $30.24 Million |
₩7.38 Billion ≈ $5.00 Million |
0.165x | -31.13% |
| 2015-12-31 | ₩36.31 Billion ≈ $24.61 Million |
₩8.72 Billion ≈ $5.91 Million |
0.240x | -- |
About NOVAREX Co.Ltd
NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science C… Read more